Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07357467
Eligibility Criteria:
Inclusion Criteria:
1. Originally assigned to either the TUDCA supplementation group or placebo control group
2. No influenza vaccination or other vaccines received between April 2025 and December 2025
3. Willing to participate in this follow-up study and sign supplementary informed consent
4. Stable health condition
Exclusion Criteria:
1. Started using immunosuppressants or hormonal medications after the original study
2. Experienced serious illness or hospitalization within the past month, or planning surgery soon
3. Experienced fever, cold, severe diarrhea, or taken influenza antiviral medications within the past month
4. Unable or unwilling to participate in blood collection
5. Lost to follow-up or unable to contact
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
60 Years
Maximum Age:
70 Years
Study:
NCT07357467
Study Brief:
Protocol Section:
NCT07357467